FIELD SHEET — CRANBERRY MFI-CRANBE-20261017-FS

Cranberry.

Name: Cranberry Evidence Field Sheet
Creator: Cypress Naturals
Published: 2026-10-17
License: https://cypressnaturals.com/terms/

Vaccinium macrocarpon, Vaccinium oxycoccos, Vaccinium vitis, Vaccinium corymbosum, Vaccinium myrtillus, Vaccinium uliginosum

Proanthocyanidin-bearing fruit; urinary-tract and cardiometabolic evidence base.

SEALED MFI-CRANBE-20261017-FS · RELEASED 2026-10-17

SHEET FINGERPRINTMFI-CRANBE-20261017-FS

544INCLUDED

2,410EXCLUDED

56DUPLICATE

134NON-TRANSFERABLE

2OUT OF CUTOFF

Survey totalsScroll ↓

3,146records surveyed

544studies

38claims graded

165observations

11,000graph nodes

Claim records

2 shown · bounded preview

RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA

CLAIM · CLM-1c29f1af9c9595b1GRADE VERY_LOW

cranberry constituents — inflammation

direction BENEFIT · dose 200 mg/kg · duration 12 weeks; 30 days; 31 day; 6 months; 8 weeks; 9 weeks

Grade basis — weakest-link ceilings

MODERATEdesign

LOWdirectness

LOWextraction

VERY_LOWconfidence

MODERATEmethodology

MODERATEconsistency

MODERATEnumeric

11bound studies

Bound studies (4 shown of 11)

STU-0c108ea12187eae7

ANIMAL · ANIMAL · 2025 · RoB INSUFFICIENT_INFORMATION

5 endpoints

STU-10dd0d4d29dd2b0d

ANIMAL · ANIMAL · 2022 · 31 day · RoB INSUFFICIENT_INFORMATION

3 endpoints

STU-2405e11d7528e27a

IN_VITRO · IN_VITRO · 2008 · RoB INSUFFICIENT_INFORMATION

2 endpoints

STU-42cc2b69ecdbd893

ANIMAL · ANIMAL · 2003 · 30 days · RoB SOME_CONCERNS

3 endpoints

Quantitative observations

duration 9 weeks · failed extraction

duration 12 weeks · failed extraction

duration 6 months · failed extraction

Opposition screen

SCREEN · 29 candidates considered · 3 bound as opposing

SYNTHESIS SYN-a763ebd3b72650 — outcome QUALITATIVE_ONLY · BENEFIT ×11 · not_assessed_quantitatively · 11 members

PROVENANCE → epmc:39996801, epmc:35268196, oax:https://openalex.org/W2168715177 · PKG dd3df1bc3380bcf3…

CLAIM · CLM-f96669e3550e200aGRADE VERY_LOW

cranberry constituents — glucose

direction BENEFIT · dose 100 mg; 200 mg/kg · duration 12 weeks; 8 weeks; 9 weeks

Grade basis — weakest-link ceilings

HIGHdesign

LOWdirectness

MODERATEextraction

LOWconfidence

MODERATEmethodology

MODERATEconsistency

MODERATEnumeric

10bound studies

Bound studies (4 shown of 10)

STU-1f27c4705571e2f1

META_ANALYSIS · HUMAN · 2025 · RoB INSUFFICIENT_INFORMATION

4 endpoints

STU-4fb66eabbc125e3a

META_ANALYSIS · HUMAN · 2022 · RoB INSUFFICIENT_INFORMATION

3 endpoints

STU-5255028078dc05f1

RCT · HUMAN · 2024 · 8 weeks · RoB SOME_CONCERNS

5 endpoints

STU-54a3a2ef18c840ee

UNSPECIFIED · HUMAN · 2025 · RoB NOT_ASSESSABLE

3 endpoints

Quantitative observations

duration 9 weeks · failed extraction

n 234 · validated

dose 100 mg · validated

Opposition screen

SCREEN · 16 candidates considered · 3 bound as opposing

SYNTHESIS SYN-0c50899c35010a — outcome QUALITATIVE_ONLY · BENEFIT ×10 · not_assessed_quantitatively · 10 members

PROVENANCE → epmc:39928643, epmc:35453306, epmc:39758261 · PKG dd3df1bc3380bcf3…

Bounded preview — representative records only. The full release ships 38 claims and 165 observations.